Association of the CFTR gene with asthma and airway mucus hypersecretion.
<h4>Introduction</h4>Asthma with airway mucus hypersecretion is an inadequately characterized variant of asthma. While several studies have reported that hypersecreting patients may carry genetic variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, many of tho...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/a6f738669bb3434cb6825f9bafdef0ea |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:a6f738669bb3434cb6825f9bafdef0ea |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:a6f738669bb3434cb6825f9bafdef0ea2021-11-25T06:23:38ZAssociation of the CFTR gene with asthma and airway mucus hypersecretion.1932-620310.1371/journal.pone.0251881https://doaj.org/article/a6f738669bb3434cb6825f9bafdef0ea2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0251881https://doaj.org/toc/1932-6203<h4>Introduction</h4>Asthma with airway mucus hypersecretion is an inadequately characterized variant of asthma. While several studies have reported that hypersecreting patients may carry genetic variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, many of those studies have been questioned for their numerous limitations and contradictory results.<h4>Objectives</h4>(1) To determine the presence of genetic variants of the CFTR gene in patients with asthma with and without airway mucus hypersecretion. (2) To identify the clinical, inflammatory and functional characteristics of the asthma phenotype with airway mucus hypersecretion.<h4>Method</h4>Comparative multicentre cross-sectional descriptive study that included 100 patients with asthma (39 hypersecretors and 61 non-hypersecretors). Asthmatic hypersecretion was defined as the presence of cough productive of sputum on most days for at least 3 months in 2 successive years. The patients were tested for fractional exhaled nitric oxide, spirometry, induced sputum cell count, total immunoglobulin E (IgE), peripheral blood eosinophil count, C-reactive protein, blood fibrinogen and blood albumin and underwent a skin prick test. Asthma control and quality of life were assessed by the Asthma Control Test and Mini Asthma Quality of Life questionnaires, respectively. Blood DNA samples were collected from the patients and next-generation sequencing using a MiSeq sequencer and the Illumina platform was used for the CFTR gene analysis.<h4>Results</h4>Genetic differences were observed in the c.1680-870T>A polymorphism of the CFTR gene, significantly more evident in hypersecretors than in non-hypersecretors: 78.94% vs. 59.32% in the majority allele and 21.05% vs. 40.67% in the minority allele (p = 0.036). Clinically, asthma hypersecretors compared to non-hypersecretors were older (57.4 years vs. 49.4 years; p = 0.004); had greater asthma severity (58.9% vs. 23.7%; p = 0.005); experienced greater airway obstruction (FEV1/FVC% 64.3 vs. 69.5; p = 0.041); had poorer asthma control (60% vs. 29%; p = 0.021); had lower IgE levels (126.4 IU/mL vs. 407.6 IU/mL; p = 0.003); and were less likely to have a positive prick test (37.5% vs. 68.85%; p = 0.011).<h4>Conclusion</h4>The results suggest that patients with asthma and with mucus hypersecretion (1) may have a different phenotype and disease mechanism produced by an intronic polymorphism in the CFTR gene (NM_000492.3:c.1680-870T>A), and (2) may have a poorer clinical outcome characterized by severe disease and poorer asthma control with a non-allergic inflammatory phenotype.Astrid Crespo-LessmannSara BernalElisabeth Del RíoEster RojasCarlos Martínez-RiveraNuria MarinaAbel Pallarés-SanmartínSilvia PascualJuan Luis García-RiveroAlicia Padilla-GaloElena CurtoCarolina CisnerosJosé SerranoMontserrat BaigetVicente PlazaEmerging Asthma GroupPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 6, p e0251881 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Astrid Crespo-Lessmann Sara Bernal Elisabeth Del Río Ester Rojas Carlos Martínez-Rivera Nuria Marina Abel Pallarés-Sanmartín Silvia Pascual Juan Luis García-Rivero Alicia Padilla-Galo Elena Curto Carolina Cisneros José Serrano Montserrat Baiget Vicente Plaza Emerging Asthma Group Association of the CFTR gene with asthma and airway mucus hypersecretion. |
| description |
<h4>Introduction</h4>Asthma with airway mucus hypersecretion is an inadequately characterized variant of asthma. While several studies have reported that hypersecreting patients may carry genetic variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, many of those studies have been questioned for their numerous limitations and contradictory results.<h4>Objectives</h4>(1) To determine the presence of genetic variants of the CFTR gene in patients with asthma with and without airway mucus hypersecretion. (2) To identify the clinical, inflammatory and functional characteristics of the asthma phenotype with airway mucus hypersecretion.<h4>Method</h4>Comparative multicentre cross-sectional descriptive study that included 100 patients with asthma (39 hypersecretors and 61 non-hypersecretors). Asthmatic hypersecretion was defined as the presence of cough productive of sputum on most days for at least 3 months in 2 successive years. The patients were tested for fractional exhaled nitric oxide, spirometry, induced sputum cell count, total immunoglobulin E (IgE), peripheral blood eosinophil count, C-reactive protein, blood fibrinogen and blood albumin and underwent a skin prick test. Asthma control and quality of life were assessed by the Asthma Control Test and Mini Asthma Quality of Life questionnaires, respectively. Blood DNA samples were collected from the patients and next-generation sequencing using a MiSeq sequencer and the Illumina platform was used for the CFTR gene analysis.<h4>Results</h4>Genetic differences were observed in the c.1680-870T>A polymorphism of the CFTR gene, significantly more evident in hypersecretors than in non-hypersecretors: 78.94% vs. 59.32% in the majority allele and 21.05% vs. 40.67% in the minority allele (p = 0.036). Clinically, asthma hypersecretors compared to non-hypersecretors were older (57.4 years vs. 49.4 years; p = 0.004); had greater asthma severity (58.9% vs. 23.7%; p = 0.005); experienced greater airway obstruction (FEV1/FVC% 64.3 vs. 69.5; p = 0.041); had poorer asthma control (60% vs. 29%; p = 0.021); had lower IgE levels (126.4 IU/mL vs. 407.6 IU/mL; p = 0.003); and were less likely to have a positive prick test (37.5% vs. 68.85%; p = 0.011).<h4>Conclusion</h4>The results suggest that patients with asthma and with mucus hypersecretion (1) may have a different phenotype and disease mechanism produced by an intronic polymorphism in the CFTR gene (NM_000492.3:c.1680-870T>A), and (2) may have a poorer clinical outcome characterized by severe disease and poorer asthma control with a non-allergic inflammatory phenotype. |
| format |
article |
| author |
Astrid Crespo-Lessmann Sara Bernal Elisabeth Del Río Ester Rojas Carlos Martínez-Rivera Nuria Marina Abel Pallarés-Sanmartín Silvia Pascual Juan Luis García-Rivero Alicia Padilla-Galo Elena Curto Carolina Cisneros José Serrano Montserrat Baiget Vicente Plaza Emerging Asthma Group |
| author_facet |
Astrid Crespo-Lessmann Sara Bernal Elisabeth Del Río Ester Rojas Carlos Martínez-Rivera Nuria Marina Abel Pallarés-Sanmartín Silvia Pascual Juan Luis García-Rivero Alicia Padilla-Galo Elena Curto Carolina Cisneros José Serrano Montserrat Baiget Vicente Plaza Emerging Asthma Group |
| author_sort |
Astrid Crespo-Lessmann |
| title |
Association of the CFTR gene with asthma and airway mucus hypersecretion. |
| title_short |
Association of the CFTR gene with asthma and airway mucus hypersecretion. |
| title_full |
Association of the CFTR gene with asthma and airway mucus hypersecretion. |
| title_fullStr |
Association of the CFTR gene with asthma and airway mucus hypersecretion. |
| title_full_unstemmed |
Association of the CFTR gene with asthma and airway mucus hypersecretion. |
| title_sort |
association of the cftr gene with asthma and airway mucus hypersecretion. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2021 |
| url |
https://doaj.org/article/a6f738669bb3434cb6825f9bafdef0ea |
| work_keys_str_mv |
AT astridcrespolessmann associationofthecftrgenewithasthmaandairwaymucushypersecretion AT sarabernal associationofthecftrgenewithasthmaandairwaymucushypersecretion AT elisabethdelrio associationofthecftrgenewithasthmaandairwaymucushypersecretion AT esterrojas associationofthecftrgenewithasthmaandairwaymucushypersecretion AT carlosmartinezrivera associationofthecftrgenewithasthmaandairwaymucushypersecretion AT nuriamarina associationofthecftrgenewithasthmaandairwaymucushypersecretion AT abelpallaressanmartin associationofthecftrgenewithasthmaandairwaymucushypersecretion AT silviapascual associationofthecftrgenewithasthmaandairwaymucushypersecretion AT juanluisgarciarivero associationofthecftrgenewithasthmaandairwaymucushypersecretion AT aliciapadillagalo associationofthecftrgenewithasthmaandairwaymucushypersecretion AT elenacurto associationofthecftrgenewithasthmaandairwaymucushypersecretion AT carolinacisneros associationofthecftrgenewithasthmaandairwaymucushypersecretion AT joseserrano associationofthecftrgenewithasthmaandairwaymucushypersecretion AT montserratbaiget associationofthecftrgenewithasthmaandairwaymucushypersecretion AT vicenteplaza associationofthecftrgenewithasthmaandairwaymucushypersecretion AT emergingasthmagroup associationofthecftrgenewithasthmaandairwaymucushypersecretion |
| _version_ |
1718413762133753856 |